US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0150-5 D-0344-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0145-5 D-0343-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0135-5 D-0342-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0125-5 D-0341-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0120-5 D-0340-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0117-5 D-0339-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0115-5 D-0338-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0113-5 D-0337-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0112-5 D-0336-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0110-5 D-0335-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0155-5 D-0334-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0140-5 D-0333-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0130-5 D-0332-2023
Class II · Moderate risk Terminated

Tirosint - Sol

Reason Subpotent Drug

Ibsa Pharma INC NDC 71858-0105-5 D-0331-2023
Class II · Moderate risk Terminated

Verapamil Hydrochloride Extended-Release Tablets

Reason Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.

Amerisource Health Services LLC D-0436-2023
Class II · Moderate risk Terminated

Ohm Sanitizer Spray

Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Urban Electric Power D-0264-2023
Class II · Moderate risk Terminated

Ohm Hand Sanitizer

Reason CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Urban Electric Power D-0263-2023
Class II · Moderate risk Terminated

Allopurinol Tablets 100mg

Reason Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.

Preferred Pharmaceuticals, Inc. D-0173-2023
Class II · Moderate risk Terminated

Diltiazem Hydrochloride Extended-Release Capsules

Reason Failed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.

Sun Pharmaceutical Industries INC NDC 47335-679-81 D-0262-2023
Class II · Moderate risk Terminated

Sterile Water for Injection

Reason CGMP Deviations: potential for trace amounts of product carryover.

Nephron Sc Inc NDC 0487-6105-01 D-0178-2023
Class II · Moderate risk Terminated

0.9% Sodium Chloride Injection

Reason CGMP Deviations: potential for trace amounts of product carryover.

Nephron Sc Inc D-0177-2023
Class II · Moderate risk Terminated

Allopurinol Tablets USP

Reason Presence of Foreign Substance: Presence of a small piece of green plastic embedded in the crack towards the edge of the tablet.

Accord Healthcare, Inc. NDC 16729-134-01 D-0168-2023
Class II · Moderate risk Terminated

Metoprolol Succinate Extended-Release Tablets

Reason Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer which included lots that were packaged for BluePoint Laboratories.

Amerisource Health Services LLC NDC 68001-501-00 D-0269-2023